| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 2,411,479 | 3,056,371 | 2,849,311 | 2,494,158 | | Cost of Revenue | 1,719,177 | 2,123,189 | 1,942,513 | 1,686,706 | | | Gross Profit | 692,302 | 933,182 | 906,798 | 807,452 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 450,624 | 502,425 | 463,717 | 417,685 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 241,678 | 430,757 | 443,081 | 389,767 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 358 | 994 | 732 | 752 | | Earnings Before Interest And Taxes | 242,036 | 431,751 | 443,813 | 390,519 | | Interest Expense | 27,524 | 33,051 | 24,169 | 16,244 | | Income Before Tax | 214,512 | 398,700 | 419,644 | 374,275 | | Income Tax Expense | 70,318 | 130,281 | 136,765 | 121,555 | | Minority Interest |
-
| (69,242) | (73,036) | (69,447) | | | | Net Income From Continuing Ops | 144,194 | 199,177 | 209,843 | 183,273 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 144,194 | 199,177 | 209,843 | 183,273 | | Preferred Stock And Other Adjustments | (47,259) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $96,935 | $199,177 | $209,843 | $183,273 |
|
0.45% Nasdaq 
0.20%
Income Statement
